These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 5845495)
1. Role of citrate in abnormal copper metabolism. Nath R; Srivastava SK Metabolism; 1965 Dec; 14(12):1237-9. PubMed ID: 5845495 [No Abstract] [Full Text] [Related]
2. The contribution of citrate to the ferroxidase activity of serum. Lee GR; Nacht S; Christensen D; Hansen SP; Cartwright GE Proc Soc Exp Biol Med; 1969 Jul; 131(3):918-23. PubMed ID: 5791811 [No Abstract] [Full Text] [Related]
3. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION]. AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395 [No Abstract] [Full Text] [Related]
4. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin. Wald I; Galewicz A; Górska D Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986 [No Abstract] [Full Text] [Related]
5. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome. MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429 [No Abstract] [Full Text] [Related]
6. Abnormal copper metabolism and hepatolenticular degeneration. DENNY-BROWN D Res Publ Assoc Res Nerv Ment Dis; 1953; 32():190-7. PubMed ID: 13134643 [No Abstract] [Full Text] [Related]
7. Introduction. Symposium on copper metabolism and Wilson's disease. Goldstein NP; Owen CA Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351 [No Abstract] [Full Text] [Related]
8. [Hepatolenticular degeneration: a new metabolic disease]. BOUDIN G; PEPIN B Presse Med (1893); 1954 Feb; 62(12):243-5. PubMed ID: 13145588 [No Abstract] [Full Text] [Related]
9. Tissue copper determinations in a case of hepatolenticular degeneration treated with BAL (dimercaprol). PALMER JF; DREW AL; CHENOWETH MB Med Bull (Ann Arbor); 1953 Nov; 19(11):308-11. PubMed ID: 13122933 [No Abstract] [Full Text] [Related]
10. [Disorders of copper and amino acid metabolism in hepato-cerebral degeneration and their treatment with BAL]. STEGER J; STEGER R Dtsch Z Nervenheilkd; 1954; 172(4):321-51. PubMed ID: 14365436 [No Abstract] [Full Text] [Related]
11. [Advances in the study of hepatolenticular degeneration]. Liu DK; Li NZ; Chen XZ; Yang YF Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):248-51. PubMed ID: 3908020 [No Abstract] [Full Text] [Related]
15. CHROMATOGRAPHIC AND MAGNETIC STUDIES ON HUMAN CERULOPLASMIN. BROMAN L Acta Soc Med Ups; 1964; 69():SUPPL 7:1-85. PubMed ID: 14229509 [No Abstract] [Full Text] [Related]
16. Identification and purification of a non-ceruloplasmin ferroxidase of human serum. Topham RW; Frieden E J Biol Chem; 1970 Dec; 245(24):6698-705. PubMed ID: 4098342 [No Abstract] [Full Text] [Related]